{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:34:43Z","timestamp":1774715683284,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.yjmcc.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T11:52:22Z","timestamp":1552305142000},"page":"231-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Bicuspid aortic valve, atherosclerosis and changes of lipid metabolism: Are there pathological molecular links?"],"prefix":"10.1016","volume":"129","author":[{"given":"Paolo","family":"Magni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2019.03.004_bb0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biochi.2018.06.023","article-title":"Integration of the human exposome with the human genome to advance medicine","volume":"152","author":"Barouki","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0015","article-title":"Prevalence, identification, and scouting for familial Hypercholesterolaemia including registries","author":"Florentin","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0020","article-title":"Markers of atherosclerosis: part 2-genetic and imaging markers","author":"Tibaut","year":"2018","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.jacc.2009.12.068","article-title":"Bicuspid aortic valve disease","volume":"55","author":"Siu","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/heart.83.1.81","article-title":"Clinical significance of the bicuspid aortic valve","volume":"83","author":"Ward","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/heartjnl-2016-309916","article-title":"Contemporary natural history of bicuspid aortic valve disease: a systematic review","volume":"103","author":"Masri","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/heart.88.4.321","article-title":"Calcification of bicuspid aortic valves","volume":"88","author":"Otto","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9149(93)90799-I","article-title":"Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves","volume":"71","author":"Beppu","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0050","article-title":"Enlightening the association between bicuspid aortic valve and Aortopathy","volume":"5","author":"Sophocleous","year":"2018","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000336147","article-title":"Aortic function: from the research laboratory to the clinic","volume":"121","author":"Boudoulas","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2009.08.080","article-title":"Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta","volume":"55","author":"Tzemos","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0065","first-page":"534","article-title":"Markers of lipid metabolism do not correlate with the expression of Aortopathy in patients with bicuspid aortic valve disease","volume":"25","author":"Sequeira Gross","year":"2016","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/nu10121912","article-title":"Dietary composition and cardiovascular risk: a mediator or a bystander?","volume":"10","author":"Korakas","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5982980","article-title":"Effectiveness of low to moderate physical exercise training on the level of low-density lipoproteins: a systematic review","volume":"2018","author":"Albarrati","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0080","article-title":"Markers of Atherosclerosis: Part 1 - Serological Markers","author":"Tibaut","year":"2018","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40292-016-0139-2","article-title":"Global cardiovascular risk assessment: strengths and limitations","volume":"23","author":"Redon","year":"2016","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0100","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in Atherothrombosis: JACC Review Topic of the Week","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000354221","article-title":"Etiology of valvular heart disease in the 21st century","volume":"126","author":"Boudoulas","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0110","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1540-8191.2009.00814.x","article-title":"Hypercholesterolemia association with aortic stenosis of various etiologies","volume":"24","author":"Rabu\u015f","year":"2009","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0120","first-page":"19","article-title":"Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting","volume":"10","author":"Novaro","year":"2001","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00246-015-1302-6","article-title":"Evaluation of cardiovascular changes in children with BAVs","volume":"37","author":"Hanedan Onan","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11748-015-0561-8","article-title":"Differing relationship between hypercholesterolemia and a bicuspid aortic valve according to the presence of aortic valve stenosis or aortic valve regurgitation","volume":"63","author":"Endo","year":"2015","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jjcc.2014.12.021","article-title":"The aortic stenosis complex: aortic valve, atherosclerosis, aortopathy","volume":"65","author":"Boudoulas","year":"2015","journal-title":"J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmg.2018.01.004","article-title":"Phenotype in girls and women with Turner syndrome: Association between dysmorphic features, karyotype and cardio-aortic malformations","volume":"61","author":"Noordman","year":"2018","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0145","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1078-5884(03)00412-X","article-title":"LDL cholesterol is associated with small abdominal aortic aneurysms","volume":"26","author":"Hobbs","year":"2003","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijcard.2007.12.082","article-title":"LDL size and subclasses in patients with abdominal aortic aneurysm","volume":"134","author":"Rizzo","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0155","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.amjcard.2009.12.076","article-title":"Association between serum lipoproteins and abdominal aortic aneurysm","volume":"105","author":"Golledge","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084517","article-title":"Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure","volume":"9","author":"Prins","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.semtcvs.2014.01.004","article-title":"Bicuspid aortic valve and associated aortopathy: an update","volume":"25","author":"Girdauskas","year":"2013","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0170","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jtcvs.2003.11.049","article-title":"Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves","volume":"127","author":"Boyum","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000034","article-title":"Impaired collagen biosynthesis and cross-linking in aorta of patients with bicuspid aortic valve","volume":"2","author":"W\u00e5gs\u00e4ter","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1196\/annals.1383.013","article-title":"Pathogenesis of thoracic and abdominal aortic aneurysms","volume":"1085","author":"Guo","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0185","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jtcvs.2006.10.083","article-title":"Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves","volume":"133","author":"Ikonomidis","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0190","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/eci.12173","article-title":"Role of the renin-angiotensin system on abdominal aortic aneurysms","volume":"43","author":"Malekzadeh","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0195","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/qjmed\/hcv032","article-title":"LDL cholesterol and apolipoprotein B are associated with ascending aorta dilatation in bicuspid aortic valve patients","volume":"108","author":"Alegret","year":"2015","journal-title":"QJM"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0200","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.113.001592","article-title":"Serum proprotein convertase subtilisin\/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation","volume":"127","author":"Tavori","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0205","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005764","article-title":"Circulating levels of Proprotein convertase Subtilisin\/Kexin type 9 and arterial stiffness in a large population sample: data from the Brisighella heart study","volume":"6","author":"Ruscica","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0210","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 Inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.06.011","article-title":"Toll-like receptor-4 signaling pathway in aorta aging and diseases: \"its double nature\"","volume":"110","author":"Balistreri","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0220","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1586\/14779072.2015.1074861","article-title":"Understanding the pathogenesis of abdominal aortic aneurysms","volume":"13","author":"Kuivaniemi","year":"2015","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tem.2016.11.002","article-title":"Context-dependent role of oxidized lipids and lipoproteins in inflammation","volume":"28","author":"Miller","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0230","article-title":"The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis","volume":"2016","author":"Roshan","year":"2016","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2018.02.007","article-title":"Targeted gene expression analyses and immunohistology suggest a pro-proliferative state in tricuspid aortic valve-, and senescence and viral infections in bicuspid aortic valve-associated thoracic aortic aneurysms","volume":"271","author":"Blunder","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0240","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0195-668X(02)00385-8","article-title":"Lipoprotein(a), chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis","volume":"24","author":"Glader","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0245","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0002-9149(99)80263-X","article-title":"Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS cardiac Echo and Cohort study)","volume":"76","author":"Gotoh","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0250","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0255","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0260","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0265","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0275","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/339301a0","article-title":"A potential basis for the thrombotic risks associated with lipoprotein(a)","volume":"339","author":"Miles","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0280","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.RES.78.4.615","article-title":"Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo","volume":"78","author":"Nielsen","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0285","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis","volume":"16","author":"O'Brien","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0295","article-title":"Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study","author":"Sticchi","year":"2018","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0300","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/ATVBAHA.110.218461","article-title":"Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve","volume":"31","author":"Paloschi","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1074\/mcp.M112.021873","article-title":"A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid- and bicuspid aortic valve","volume":"12","author":"Kjellqvist","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0310","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1515\/cclm-2015-0953","article-title":"Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases","volume":"54","author":"Magni","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0315","doi-asserted-by":"crossref","first-page":"H5","DOI":"10.1152\/ajpheart.00824.2009","article-title":"Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology","volume":"298","author":"Rajamannan","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0320","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and lung and blood institute aortic stenosis working group. Executive summary: calcific aortic valve disease-2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0325","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/heartjnl-2014-305509","article-title":"Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve","volume":"100","author":"Ali","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0330","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcb.24031","article-title":"Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(\u2212\/\u2212) null mice","volume":"113","author":"Rajamannan","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0335","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/eurheartj\/ehq479","article-title":"Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis","volume":"32","author":"Akahori","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0340","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCULATIONAHA.115.016006","article-title":"Drug therapy for heart valve diseases","volume":"132","author":"Borer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0345","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tcm.2017.12.011","article-title":"LDL cholesterol: how low to go?","volume":"28","author":"Packard","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0350","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejvs.2005.02.044","article-title":"HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms","volume":"30","author":"Wilson","year":"2005","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0355","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.3390\/ijms160511213","article-title":"Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue","volume":"16","author":"Yoshimura","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0360","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/hc4301.098249","article-title":"Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis","volume":"104","author":"Novaro","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0365","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.amjcard.2011.06.071","article-title":"Comparison of ascending aortic size in patients with severe bicuspid aortic valve stenosis treated with versus without a statin drug","volume":"108","author":"Goel","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0370","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/qjmed\/hcy129","article-title":"Does statin therapy impact the proximal aortopathy in aortic valve disease?","volume":"111","author":"Sequeira Gross","year":"2018","journal-title":"QJM"},{"key":"10.1016\/j.yjmcc.2019.03.004_bb0375","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818310915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818310915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:28:55Z","timestamp":1758313735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818310915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":75,"alternative-id":["S0022282818310915"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.004","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bicuspid aortic valve, atherosclerosis and changes of lipid metabolism: Are there pathological molecular links?","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}